Patents and Health

• Our brief review of the UNCTAD technology transfer literature does not suggest any robust attempt to link local production and access to medicines but this may not

The doses or regimens used for the treatment of many NTDs are not always based on solid pharmacological, efficacy and safety information, and in many instances do not address

Moxidectin (a macrocyclic lactone registered worldwide (including the United States of America, USA) for prevention of canine heartworm and treatment of parasites in cattle,

One of these processes is the WHO Coordinated Scientific Advice (CSA) procedure for health product research and development (R&D) whereby product developers may approach WHO

4.1 Current guidance suggests that a district-level prevalence of TF in 1-9 year-old children of 10% or more is a public health problem justifying implementation of the

The Western Pacific Regional Action Agenda on Regulatory Strengthening, Convergence and Cooperation for Medicines and the Health Workforce guides Member States in

To address this challenge, the Fifty-first and the Fifty-fourth Sessions of the Regional Committee for the Eastern Mediterranean adopted – in October 2004 and 2007, respectively

A researcher will be better placed to conduct ethical research if they are mindful of the context they are working in and make a proactive effort to respect, and ensure benefits